Charles River

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

O’Leary Targets AI Infrastructure

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Markets

$BTC

$ETH

COIN

HOOD

Il noto investitore condivide la sua strategia minimale per navigare i mercati digitali più imprevedibili e cogliere i rendimenti maggiori.

Kevin O&#39;Leary: bastano BTC ed ETH per dominare la volatilità crypto

Usdc,Usd,Coin,Stablecoin,Cryptocurrency,Golden,Coin,In,Hand,Abstract

$SOL

$USDC

SHOP

USDC

Tobi Lütke, CEO di Shopify Inc. (NASDAQ:SHOP), ha annunciato giovedì che la sua firm ha stretto una partnership strategica con Coinbase Global Inc. (NASDAQ:

Shopify con Coinbase e Stripe per lanciare pagamenti in stablecoin

Exclusives

$USDT

Tarun Anand, consulente di KPMG per Blockchain e Asset Digitali, ha affermato che le stablecoin, la tokenizzazione di asset del mondo reale e le reti di infrastrutture fisiche decentralizzate (DePIN) saranno le principali narrazioni crypto da tenere d’occhio nei prossimi anni.

Il futuro delle crypto: esperto rivela su cosa scommettere ora

Charles River Laboratories International, Inc. Common Stock

Charles River Laboratories International Inc

Cresco Labs Inc

CARDINAL ENERGY LTD ORD by Cardinal Energy Ltd.

Cardinal Energy Ltd

CORCEL EXPL INC by CORCEL EXPL INC

CENTRAL PRKNG F/T 5.25PFD by Central Parking Finance Trust

Central Parking Financial Trust

Cerillion PLC

Press Releases

Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call

Charles River Joins Elly's Team to Drive Rare Disease Gene Therapy Development

Charles River and BioTech Social Inc. Pursue Crowdfunding Partnership

Charles River Laboratories Announces Second-Quarter 2025 Results

Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing

Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer

Charles River Laboratories Announces Chief Financial Officer Transition

Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing

Agilent Technologies

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Avantor

Azenta

Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories

Bruker

Danaher

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

Charles River

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO